J Korean Neurosurg Soc.  2018 Mar;61(2):127-166. 10.3340/jkns.2017.0404.005.

Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage

• Cho WS
• Kim JE
• Park SQ
• Ko JK
• Kim DW
• Park JC
• Yeon JY
• Chung SY
• Chung J
• Joo SP
• Hwang G
• Kim DY
• Chang WH
• Choi KS
• Lee SH
• Sheen SH
• Kang HS
• Kim BM
• Bae HJ
• Oh CW
• Park HS
• Quality Control Committees from the Korean Society of Cerebrovascular Surgeons
• Society of Korean Endovascular Neurosurgeons
• Korean Society of Interventional Neuroradiology
• Korean Stroke Society and Korean Academy of Rehabilitation Medicine

• KMID: 2408016
• DOI: http://doi.org/10.3340/jkns.2017.0404.005

Abstract

Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a high rate of morbidity and mortality. Based on the literature published to date, worldwide academic and governmental committees have developed clinical practice guidelines (CPGs) to propose standards for disease management in order to achieve the best treatment outcomes for aSAHs. In 2013, the Korean Society of Cerebrovascular Surgeons issued a Korean version of the CPGs for aSAHs. The group researched all articles and major foreign CPGs published in English until December 2015 using several search engines. Based on these articles, levels of evidence and grades of recommendations were determined by our society as well as by other related Quality Control Committees from neurointervention, neurology and rehabilitation medicine. The Korean version of the CPGs for aSAHs includes risk factors, diagnosis, initial management, medical and surgical management to prevent rebleeding, management of delayed cerebral ischemia and vasospasm, treatment of hydrocephalus, treatment of medical complications and early rehabilitation. The CPGs are not the absolute standard but are the present reference as the evidence is still incomplete, each environment of clinical practice is different, and there is a high probability of variation in the current recommendations. The CPGs will be useful in the fields of clinical practice and research.

Keyword

Aneurysmal subarachnoid hemorrhage; Clinical practice guideline; Korean version

MeSH Terms

Aneurysm*
Brain Ischemia
Cerebrovascular Disorders
Diagnosis
Disease Management
Hydrocephalus
Intracranial Aneurysm
Mortality
Neurology
Quality Control
Rehabilitation
Risk Factors
Search Engine
Subarachnoid Hemorrhage*
Surgeons

Reference

References

1. Abruzzo T, Moran C, Blackham KA, Eskey CJ, Lev R, Meyers P, et al. Invasive interventional management of post-hemorrhagic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurointerv Surg. 4:169–177. 2012.

2. Agid R, Andersson T, Almqvist H, Willinsky RA, Lee SK, terBrugge KG, et al. Negative CT angiography findings in patients with spontaneous subarachnoid hemorrhage: when is digital subtraction angiography still needed? AJNR Am J Neuroradiol. 31:696–705. 2010.

3. Al-Rawi PG, Tseng MY, Richards HK, Nortje J, Timofeev I, Matta BF, et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow, brain tissue oxygen, and pH. Stroke. 41:122–128. 2010.

4. Alberti O, Becker R, Benes L, Wallenfang T, Bertalanffy H. Initial hyperglycemia as an indicator of severity of the ictus in poor-grade patients with spontaneous subarachnoid hemorrhage. Clin Neurol Neurosurg. 102:78–83. 2000.

5. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al. Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med. 308:619–624. 1983.

6. Al-Tamimi YZ, Bhargava D, Feltbower RG, Hall G, Goddard AJ, Quinn AC, et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 43:677–682. 2012.

7. Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery. 44:1113–1116. 1999.

8. Anderson SW, Todd MM, Hindman BJ, Clarke WR, Torner JC, Tranel D, et al. Effects of intraoperative hypothermia on neuropsychological outcomes after intracranial aneurysm surgery. Ann Neurol. 60:518–527. 2006.

9. Ando T, Sakai N, Yamada H, Iwai T, Nishimura Y, Hirata T, et al. Analysis of reruptured cerebral aneurysms and the prophylactic effects of barbiturate therapy on the early stage. Neurol Res. 11:245–248. 1989.

10. Appelboom G, Strozyk D, Hwang BY, Prowda J, Badjatia N, Helbok R, et al. Bedside use of a dual aortic balloon occlusion for the treatment of cerebral vasospasm. Neurocrit Care. 13:385–388. 2010.

11. Asberg KH, Nydevik I. Early prognosis of stroke outcome by means of katz index of activities of daily living. Scand J Rehabil Med. 23:187–191. 1991.

12. Auer LM, Mokry M. Disturbed cerebrospinal fluid circulation after subarachnoid hemorrhage and acute aneurysm surgery. Neurosurgery. 26:804–808. discussion 808–809. 1990.

13. Badjatia N, Topcuoglu MA, Buonanno FS, Smith EE, Nogueira RG, Rordorf GA, et al. Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage. Crit Care Med. 33:1603–1609. quiz 1623. 2005.

14. Bae DH, Kim JM, Won YD, Choi KS, Cheong JH, Yi HJ, et al. Clinical outcome of paraclinoid internal carotid artery aneurysms after microsurgical neck clipping in comparison with endovascular embolization. J Cerebrovasc Endovasc Neurosurg. 16:225–234. 2014.

15. Bae IS, Yi HJ, Choi KS, Chun HJ. Comparison of incidence and risk factors for shunt-dependent hydrocephalus in aneurysmal subarachnoid hemorrhage patients. J Cerebrovasc Endovasc Neurosurg. 16:78–84. 2014.

16. Baharoglu MI, Germans MR, Rinkel GJ, Algra A, Vermeulen M, van Gijn J, et al. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. (8):CD001245. 2013.

17. Baker CJ, Prestigiacomo CJ, Solomon RA. Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery. 37:863–870. discussion 870–871. 1995.

18. Bakker NA, Groen RJ, Foumani M, Uyttenboogaart M, Eshghi OS, Metzemaekers JD, et al. Repeat digital subtraction angiography after a negative baseline assessment in nonperimesencephalic subarachnoid hemorrhage: a pooled data meta-analysis. J Neurosurg. 120:99–103. 2014.

19. Barth M, Capelle HH, Weidauer S, Weiss C, Münch E, Thomé C, et al. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke. 38:330–336. 2007.

20. Barth M, Pena P, Seiz M, Thomé C, Muench E, Weidauer S, et al. Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage. Br J Neurosurg. 25:677–683. 2011.

21. Bassi P, Bandera R, Loiero M, Tognoni G, Mangoni A. Warning signs in subarachnoid hemorrhage: a cooperative study. Acta Neurol Scand. 84:277–281. 1991.

22. Bebawy JF, Zeeni C, Sharma S, Kim ES, DeWood MS, Hemmer LB, et al. Adenosine-induced flow arrest to facilitate intracranial aneurysm clip ligation does not worsen neurologic outcome. Anesth Analg. 117:1205–1210. 2013.

23. Bellolio MF, Hess EP, Gilani WI, VanDyck TJ, Ostby SA, Schwarz JA, et al. External validation of the Ottawa subarachnoid hemorrhage clinical decision rule in patients with acute headache. Am J Emerg Med. 33:244–249. 2015.

24. Bendok BR, Gupta DK, Rahme RJ, Eddleman CS, Adel JG, Sherma AK, et al. Adenosine for temporary flow arrest during intracranial aneurysm surgery: a single-center retrospective review. Neurosurgery. 69:815–820. discussion 820–821. 2011.

25. Benech CA, Perez R, Faccani G, Trompeo AC, Cavallo S, Beninati S, et al. Adenosine-induced cardiac arrest in complex cerebral aneurysms surgery: an Italian single-center experience. J Neurosurg Sci. 58:87–94. 2014.

26. Bentsen G, Breivik H, Lundar T, Stubhaug A. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit Care Med. 34:2912–2917. 2006.

27. Bian L, Liu L, Wang C, Hussain M, Yuan Y, Liu G, et al. Hyperglycemia within day 14 of aneurysmal subarachnoid hemorrhage predicts 1-year mortality. Clin Neurol Neurosurg. 115:956–964. 2013.

28. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol. 19:156–160. 2007.

29. Black PM, Baker MF, Snook CP. Experience with external pneumatic calf compression in neurology and neurosurgery. Neurosurgery. 18:440–444. 1986.

30. Bodily KD, Cloft HJ, Lanzino G, Fiorella DJ, White PM, Kallmes DF. Stent-assisted coiling in acutely ruptured intracranial aneurysms: a qualitative, systematic review of the literature. AJNR Am J Neuroradiol. 32:1232–1236. 2011.

31. Bonita R. Cigarette smoking, hypertension and the risk of subarachnoid hemorrhage: a population-based case-control study. Stroke. 17:831–835. 1986.

32. Bor AS, Koffijberg H, Wermer MJ, Rinkel GJ. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology. 74:1671–1679. 2010.

33. Bor AS, Rinkel GJ, Adami J, Koffijberg H, Ekbom A, Buskens E, et al. Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain. 131(Pt 10):2662–2665. 2008.

34. Bor AS, Rinkel GJ, van Norden J, Wermer MJ. Long-term, serial screening for intracranial aneurysms in individuals with a family history of aneurysmal subarachnoid haemorrhage: a cohort study. Lancet Neurol. 13:385–392. 2014.

35. Bor AS, Tiel Groenestege AT, terBrugge KG, Agid R, Velthuis BK, Rinkel GJ, et al. Clinical, radiological, and flow-related risk factors for growth of untreated, unruptured intracranial aneurysms. Stroke. 46:42–48. 2015.

36. Bota DP, Lefranc F, Vilallobos HR, Brimioulle S, Vincent JL. Ventriculostomy-related infections in critically ill patients: a 6-year experience. J Neurosurg. 103:468–472. 2005.

37. Bracard S, Lebedinsky A, Anxionnat R, Neto JM, Audibert G, Long Y, et al. Endovascular treatment of Hunt and Hess grade IV and V aneurysms. AJNR Am J Neuroradiol. 23:953–957. 2002.

38. Brilstra EH, Rinkel GJ, van der Graaf Y, van Rooij WJ, Algra A. Treatment of intracranial aneurysms by embolization with coils: a systematic review. Stroke. 30:470–476. 1999.

39. Brinjikji W, Kallmes DF, White JB, Lanzino G, Morris JM, Cloft HJ. Inter-and intraobserver agreement in CT characterization of nonaneurysmal perimesencephalic subarachnoid hemorrhage. AJNR Am J Neuroradiol. 31:1103–1105. 2010.

40. Broderick JP, Brown RD Jr, Sauerbeck L, Hornung R, Huston J 3rd, Woo D, et al. Greater rupture risk for familial as compared to sporadic unruptured intracranial aneurysms. Stroke. 40:1952–1957. 2009.

41. Bromberg JE, Rinkel GJ, Algra A, Greebe P, Beldman T, van Gijn J. Validation of family history in subarachnoid hemorrhage. Stroke. 27:630–632. 1996.

42. Bromberg JE, Rinkel GJ, Algra A, Greebe P, van Duyn CM, Hasan D, et al. Subarachnoid haemorrhage in first and second degree relatives of patients with subarachnoid haemorrhage. BMJ. 311:288–289. 1995.

43. Bruder N, Rabinstein A; Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Cardiovascular and pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurocrit Care. 15:257–269. 2011.

44. Burns JD, Huston J 3rd, Layton KF, Piepgras DG, Brown RD Jr. Intracranial aneurysm enlargement on serial magnetic resonance angiography: frequency and risk factors. Stroke. 40:406–411. 2009.

45. Butzkueven H, Evans AH, Pitman A, Leopold C, Jolley DJ, Kaye AH, et al. Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology. 55:1315–1320. 2000.

46. Campi A, Ramzi N, Molyneux AJ, Summers PE, Kerr RS, Sneade M, et al. Retreatment of ruptured cerebral aneurysms in patients randomized by coiling or clipping in the International Subarachnoid Aneurysm Trial (ISAT). Stroke. 38:1538–1544. 2007.

47. Canhão P, Pinto AN, Ferro H, Ferro JM. Smoking and aneurysmal subarachnoid haemorrhage: a case-control study. J Cardiovasc Risk. 1:155–158. 1994.

48. Carhuapoma JR, Gupta K, Coplin WM, Muddassir SM, Meratee MM. Treatment of refractory fever in the neurosciences critical care unit using a novel, water-circulating cooling device. A single center pilot experience. J Neurosurg Anesthesiol. 15:313–318. 2003.

49. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking--a study of male twins. N Engl J Med. 327:829–833. 1992.

50. Cha KC, Kim JH, Kang HI, Moon BG, Lee SJ, Kim JS. Aneurysmal rebleeding : factors associated with clinical outcome in the rebleeding patients. J Korean Neurosurg Soc. 47:119–123. 2010.

51. Chang HS, Hongo K, Nakagawa H. Adverse effects of limited hypotensive anesthesia on the outcome of patients with subarachnoid hemorrhage. J Neurosurg. 92:971–975. 2000.

52. Chang IB, Cho BM, Shin DI, Shim YB, Park SH, Oh SM. Risk of seizures after operative treatment of ruptured cerebral aneurysms. J Korean Neurosurg Soc. 30:705–710. 2001.

53. Chumnanvej S, Dunn IF, Kim DH. Three-day phenytoin prophylaxis is adequate after subarachnoid hemorrhage. Neurosurgery. 60:99–102. discussion 102–103. 2007.

54. Cifu DX, Stewart DG. Factors affecting functional outcome after stroke: a critical review of rehabilitation interventions. Arch Phys Med Rehabil. 80(5 Suppl 1):S35–S39. 1999.

55. Claassen J, Bateman BT, Willey JZ, Inati S, Hirsch LJ, Mayer SA, et al. Generalized convulsive status epilepticus after nontraumatic subarachnoid hemorrhage: the nationwide inpatient sample. Neurosurgery. 61:60–64. discussion 64–65. 2007.

56. Claassen J, Vu A, Kreiter KT, Kowalski RG, Du EY, Ostapkovich N, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med. 32:832–838. 2004.

57. Committee for Guidelines for Management of Aneurysmal Subarachnoid Hemorrhage, Japanese Society on Surgery for Cerebral Stroke. Evidence-based guidelines for the management of aneurysmal subarachnoid hemorrhage. English edition. Neurol Med Chir (Tokyo). 52:355–429. 2012.

58. Cong W, Zhongxin Z, Tiangui L, Zhang Y, Min H, Chao Y. Risk factors for rebleeding of aneurysmal subarachnoid hemorrhage based on the analysis of on-admission information. Turk Neurosurg. 22:675–681. 2012.

59. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 43:1711–1737. 2012.

60. Cortnum S, Sørensen P, Jørgensen J. Determining the sensitivity of computed tomography scanning in early detection of subarachnoid hemorrhage. Neurosurgery. 66:900–902. discussion 903. 2010.

61. Cremers CH, van der Schaaf IC, Wensink E, Greving JP, Rinkel GJ, Velthuis BK, et al. CT perfusion and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 34:200–207. 2014.

62. Dankbaar JW, de Rooij NK, Velthuis BK, Frijns CJ, Rinkel GJ, van der Schaaf IC. Diagnosing delayed cerebral ischemia with different CT modalities in patients with subarachnoid hemorrhage with clinical deterioration. Stroke. 40:3493–3498. 2009.

63. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care. 14:R23. 2010.

64. de Falco FA. Sentinel headache. Neurol Sci. 25(Suppl 3):S215–S217. 2004.

65. de Gans K, Nieuwkamp DJ, Rinkel GJ, Algra A. Timing of aneurysm surgery in subarachnoid hemorrhage: a systematic review of the literature. Neurosurgery. 50:336–340. discussion 340–342. 2002.

66. de Oliveira JG, Beck J, Setzer M, Gerlach R, Vatter H, Seifert V, et al. Risk of shunt-dependent hydrocephalus after occlusion of ruptured intracranial aneurysms by surgical clipping or endovascular coiling: a single-institution series and meta-analysis. Neurosurgery. 61:924–933. discussion 933–934. 2007.

67. De Sloovere VT. Anesthesia for embolization of cerebral aneurysms. Curr Opin Anaesthesiol. 27:431–436. 2014.

68. Dehdashti AR, Rilliet B, Rufenacht DA, de Tribolet N. Shunt-dependent hydrocephalus after rupture of intracranial aneurysms: a prospective study of the influence of treatment modality. J Neurosurg. 101:402–407. 2004.

69. Delgado Almandoz JE, Kadkhodayan Y, Crandall BM, Scholz JM, Fease JL, Anderson RE, et al. Diagnostic yield of delayed neurovascular imaging in patients with subarachnoid hemorrhage, negative initial CT and catheter angiograms, and a negative 7 day repeat catheter angiogram. J Neurointerv Surg. 6:637–642. 2014.

70. Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke. 40:3039–3044. 2009.

71. Dhar S, Tremmel M, Mocco J, Kim M, Yamamoto J, Siddiqui AH, et al. Morphology parameters for intracranial aneurysm rupture risk assessment. Neurosurgery. 63:185–196. discussion 196–197. 2008.

72. Diringer MN; Neurocritical Care Fever Reduction Trial Group. Treatment of fever in the neurologic intensive care unit with a catheter-based heat exchange system. Crit Care Med. 32:559–564. 2004.

73. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients. Crit Care Med. 32:1489–1495. 2004.

74. Donmez H, Serifov E, Kahriman G, Mavili E, Durak AC, Menkü A. Comparison of 16-row multislice CT angiography with conventional angiography for detection and evaluation of intracranial aneurysms. Eur J Radiol. 80:455–461. 2011.

75. Dorai Z, Hynan LS, Kopitnik TA, Samson D. Factors related to hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery. 52:763–769. discussion 769–771. 2003.

76. Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, et al. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial. Lancet. 380:44–49. 2012.

77. Dorhout Mees SM, Molyneux AJ, Kerr RS, Algra A, Rinkel GJ. Timing of aneurysm treatment after subarachnoid hemorrhage: relationship with delayed cerebral ischemia and poor outcome. Stroke. 43:2126–2129. 2012.

78. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. (4):CD006184. 2007.

79. Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 78:729–731. 2007.

80. Dorhout Mees SM, van Dijk GW, Algra A, Kempink DR, Rinkel GJ. Glucose levels and outcome after subarachnoid hemorrhage. Neurology. 61:1132–1133. 2003.

81. Duncan PW, Horner RD, Reker DM, Samsa GP, Hoenig H, Hamilton B, et al. Adherence to postacute rehabilitation guidelines is associated with functional recovery in stroke. Stroke. 33:167–177. 2002.

82. Dupont SA, Lanzino G, Wijdicks EF, Rabinstein AA. The use of clinical and routine imaging data to differentiate between aneurysmal and nonaneurysmal subarachnoid hemorrhage prior to angiography. Clinical article. J Neurosurg. 113:790–794. 2010.

83. Edlow JA. Diagnosis of subarachnoid hemorrhage. Neurocrit Care. 2:99–109. 2005.

84. Edlow JA. Diagnosing headache in the emergency department: what is more important? Being right, or not being wrong? Eur J Neurol. 15:1257–1258. 2008.

85. Eskridge JM, Song JK. Endovascular embolization of 150 basilar tip aneurysms with guglielmi detachable coils: results of the Food and Drug Administration multicenter clinical trial. J Neurosurg. 89:81–86. 1998.

86. Farrar JK, Gamache FW Jr, Ferguson GG, Barker J, Varkey GP, Drake CG. Effects of profound hypotension on cerebral blood flow during surgery for intracranial aneurysms. J Neurosurg. 55:857–864. 1981.

87. Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid hemorrhage and primary intracerebral hemorrhage. Cochrane Database of Syst Rev. (3):CD004583. 2005.

88. Feigin VL, Rinkel GJ, Lawes CM, Algra A, Bennett DA, van Gijn J, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke. 36:2773–2780. 2005.

89. Fernandez A, Schmidt JM, Claassen J, Pavlicova M, Huddleston D, Kreiter KT, et al. Fever after subarachnoid hemorrhage: risk factors and impact on outcome. Neurology. 68:1013–1019. 2007.

90. Fiebach JB, Schellinger PD, Geletneky K, Wilde P, Meyer M, Hacke W, et al. MRI in acute subarachnoid haemorrhage; findings with a standardised stroke protocol. Neuroradiology. 46:44–48. 2004.

91. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 6:1–9. 1980.

92. Fontes RB, Aguiar PH, Zanetti MV, Andrade F, Mandel M, Teixeira MJ. Acute neurogenic pulmonary edema: case reports and literature review. J Neurosurg Anesthesiol. 15:144–150. 2003.

93. Foreman PM, Chua M, Harrigan MR, Fisher WS 3rd, Tubbs RS, Shoja MM, et al. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: a case-control study. Clin Neurol Neurosurg. 139:66–69. 2015.

94. Foroohar M, Macdonald RL, Roth S, Stoodley M, Weir B. Intraoperative variables and early outcome after aneurysm surgery. Surg Neurol. 54:304–315. 2000.

95. Friedman JA, Pichelmann MA, Piepgras DG, Mclver JI, Toussaint LG 3rd, McClelland RL, et al. Pulmonary complications of aneurysmal subarachnoid hemorrhage. Neurosurgery. 52:1025–1031. discussion 1031–1032. 2003.

96. Frontera JA, Fernandez A, Claassen J, Schmidt M, Schumacher HC, Wartenberg K, et al. Hyperglycemia after SAH: predictors, associated complications, and impact on outcome. Stroke. 37:199–203. 2006.

97. Frontera JA, Parra A, Shimbo D, Fernandez A, Schmidt JM, Peter P, et al. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovasc Dis. 26:71–78. 2008.

98. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 84:35–42. 1996.

99. Gaberel T, Magheru C, Emery E, Derlon JM. Antifibrinolytic therapy in the management of aneurismal subarachnoid hemorrhage revisited. A meta-analysis. Acta Neurochir (Wien). 154:1–9. discussion 9. 2012.

100. Gathier CS, van den Bergh WM, Slooter AJ; HIMALAIA-Study Group. HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage. Int J Stroke. 9:375–380. 2014.

101. Germans MR, Coert BA, Vandertop WP, Verbaan D. Time intervals from subarachnoid hemorrhage to rebleed. J Neurol. 261:1425–1431. 2014.

102. Giannotta SL, Oppenheimer JH, Levy ML, Zelman V. Management of intraoperative rupture of aneurysm without hypotension. Neurosurgery. 28:531–535. discussion 535–536. 1991.

103. Giller CA, Wills MJ, Giller AM, Samson D. Distribution of hematocrit values after aneurysmal subarachnoid hemorrhage. J Neuroimaging. 8:169–170. 1998.

104. Gilsbach JM, Harders AG. Morbidity and mortality after early aneurysm surgery--a prospective study with nimodipine prevention. Acta Neurochir (Wien). 96:1–7. 1989.

105. Golan E, Vasquez DN, Ferguson ND, Adhikari NK, Scales DC. Prophylactic magnesium for improving neurologic outcome after aneurysmal subarachnoid hemorrhage: systematic review and meta-analysis. J Crit Care. 28:173–181. 2013.

106. Gollwitzer S, Groemer T, Rampp S, Hagge M, Olmes D, Huttner HB, et al. Early prediction of delayed cerebral ischemia in subarachnoid hemorrhage based on quantitative EEG: a prospective study in adults. Clin Neurophysiol. 126:1514–1523. 2015.

107. Greebe P, Bromberg JE, Rinkel GJ, Algra A, van Gijn J. Family history of subarachnoid haemorrhage: supplemental value of scrutinizing all relatives. J Neurol Neurosurg Psychiatry. 62:273–275. 1997.

108. Groden C, Kremer C, Regelsberger J, Hansen HC, Zeumer H. Comparison of operative and endovascular treatment of anterior circulation aneurysms in patients in poor grades. Neuroradiology. 43:778–783. 2001.

109. Gruber A, Killer M, Bavinzski G, Richling B. Clinical and angiographic results of endosaccular coiling treatment of giant and very large intracranial aneurysms: a 7-year, single-center experience. Neurosurgery. 45:793–803. discussion 803–804. 1999.

110. Gruber A, Reinprecht A, Bavinzski G, Czech T, Richling B. Chronic shunt-dependent hydrocephalus after early surgical and early endovascular treatment of ruptured intracranial aneurysms. Neurosurgery. 44:503–509. discussion 509–512. 1999.

111. Gruber A, Reinprecht A, Görzer H, Fridrich P, Czech T, Illievich UM, et al. Pulmonary function and radiographic abnormalities related to neurological outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 88:28–37. 1998.

112. Gruber A, Reinprecht A, Illievich UM, Fitzgerald R, Dietrich W, Czech T, et al. Extracerebral organ dysfunction and neurologic outcome after aneurysmal subarachnoid hemorrhage. Crit Care Med. 27:505–514. 1999.

113. Guinn NR, McDonagh DL, Borel CO, Wright DR, Zomorodi AR, Powers CJ, et al. Adenosine-induced transient asystole for intracranial aneurysm surgery: a retrospective review. J Neurosurg Anesthesiol. 23:35–40. 2011.

114. Guo LM, Zhou HY, Xu JW, Wang Y, Qiu YM, Jiang JY. Risk factors related to aneurysmal rebleeding. World Neurosurg. 76:292–298. discussion 253–254. 2011.

115. Güresir E, Schuss P, Setzer M, Platz J, Seifert V, Vatter H. Posterior communicating artery aneurysm-related oculomotor nerve palsy: influence of surgical and endovascular treatment on recovery: single-center series and systematic review. Neurosurgery. 68:1527–1533. discussion 1533–1534. 2011.

116. Hart Y, Sneade M, Birks J, Rischmiller J, Kerr R, Molyneux A. Epilepsy after subarachnoid hemorrhage: the frequency or seizures after clip occlusion or coil embolization of a ruptured cerebral aneurysm: results from the International Subarachnoid Aneurysm Trial. J Neurosurg. 115:1159–1168. 2011.

117. Hasan D, Lindsay KW, Wijdicks EF, Murray GD, Brouwers PJ, Bakker WH, et al. Effect of fludrocortisone acetate in patients with subarachnoid hemorrhage. Stroke. 20:1156–1161. 1989.

118. Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke. 20:747–753. 1989.

119. Hasan D, Wijdicks EF, Vermeulen M. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage. Ann Neurol. 27:106–108. 1990.

120. Hayakawa M, Murayama Y, Duckwiler GR, Gobin YP, Guglielmi G, Viñuela F. Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system. J Neurosurg. 93:561–568. 2000.

121. Hayes SH, Carroll SR. Early intervention care in the acute stroke patient. Arch Phys Med Rehabil. 67:319–321. 1986.

122. Helbok R, Schmidt JM, Kurtz P, Hanafy KA, Fernandez L, Stuart RM, et al. Systemic glucose and brain energy metabolism after subarachnoid hemorrhage. Neurocrit Care. 12:317–323. 2010.

123. Hellingman CA, van den Bergh WM, Beijer IS, van Dijk GW, Algra A, van Gijn J, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke. 38:96–99. 2007.

124. Henderson WG, Torner JC, Nibbelink DW. Intracranial aneurysms and subarachnoid hemorrhage --- report on a randomized treatment study. IV-B Regulated bed rest --- statistical evaluation. Stroke. 8:579–589. 1977.

125. Hernesniemi J, Koivisto T. Comments on “The impact of the International Subarachnoid Aneurysm Treatment Trial (ISAT) on neurosurgical practice”. Acta Neurochir (Wien). 146:203–208. 2004.

126. Heros RC. Acute hydrocephalus after subarachnoid hemorrhage. Stroke. 20:715–717. 1989.

127. Hijdra A, Vermeulen M, van Gijn J, van Crevel H. Rerupture of intracranial aneurysms: a clinicoanatomic study. J Neurosurg. 67:29–33. 1987.

128. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 97:771–778. 2002.

129. Hindman BJ, Bayman EO, Pfisterer WK, Torner JC, Todd MM; IHAST Investigators. No association between intraoperative hypothermia or supplemental protective drug and neurologic outcomes in patients undergoing temporary clipping during cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology. 112:86–101. 2010.

130. Hitchcock ER, Tsementzis SA, Dow AA. Short- and long-term prognosis of patients with a subarachnoid haemorrhage in relation to intraoperative period of hypotension. Acta Neurochir (Wien). 70:235–242. 1984.

131. Hoff RG, Van Dijk GW, Mettes S, Verweij BH, Algra A, Rinkel GJ, et al. Hypotension in anaesthetized patients during aneurysm clipping: not as bad as expected? Acta Anaesthesiol Scand. 52:1006–1011. 2008.

132. Hoh BL, Carter BS, Budzik RF, Putman CM, Ogilvy CS. Results after surgical and endovascular treatment of paraclinoid aneurysms by a combined neurovascular team. Neurosurgery. 48:78–89. discussion 89–90. 2001.

133. Hoh BL, Nathoo S, Chi YY, Mocco J, Barker FG 2nd. Incidence of seizures or epilepsy after clipping or coiling or ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002–2007. Neurosurgery. 69:644–650. discussion 650. 2011.

134. Hoh BL, Sistrom CL, Firment CS, Fautheree GL, Velat GJ, Whiting JH, et al. Bottleneck factor and height-width ratio: association with ruptured aneurysms in patients with multiple cerebral aneurysms. Neurosurgery. 61:716–722. discussion 722–723. 2007.

135. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 28:14–20. 1968.

136. Huttner HB, Nagel S, Tognoni E, Köhrmann M, Jüttler E, Orakcioglu B, et al. Intracerebral hemorrhage with severe ventricular involvement: lumbar drainage for communicating hydrocephalus. Stroke. 38:183–187. 2007.

137. Huttner HB, Schwab S, Bardutzky J. Lumbar drainage for communicating hydrocephalus after ICH with ventricular hemorrhage. Neurocrit Care. 5:193–196. 2006.

138. Ibrahim GM, Macdonald RL. The effects of fluid balance and colloid administration on outcomes in patients with aneurysmal subarachnoid hemorrhage: a propensity score-matched analysis. Neurocrit Care. 19:140–149. 2013.

139. Jakobsson KE, Säveland H, Hillman J, Edner G, Zygmunt S, Brandt L, et al. Warning leak and management outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg. 85:995–999. 1996.

140. Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR, et al. Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke. 39:120–125. 2008.

141. Jones M, Leslie K, Mitchell P. Anaesthesia for endovascular treatment of cerebral aneurysms. J Clin Neurosci. 11:468–470. 2004.

142. Jost SC, Diringer MN, Zazulia AR, Videen TO, Aiyagari V, Grubb RL, et al. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg. 103:25–30. 2005.

143. Jun P, Ko NU, English JD, Dowd CF, Halbach VV, Higashida RT, et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol. 31:1911–1916. 2010.

144. Juvela S. Risk factors for multiple intracranial aneurysms. Stroke. 31:392–397. 2000.

145. Juvela S, Hillbom M, Numminen H, Koskinen P. Cigarette smoking and alcohol consumption as risk factors for aneurysmal subarachnoid hemorrhage. Stroke. 24:639–646. 1993.

146. Juvela S, Porras M, Poussa K. Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture. J Neurosurg. 93:379–387. 2000.

147. Juvela S, Poussa K, Lehto H, Porras M. Natural history of unruptured intracranial aneurysms: a long-term follow-up study. Stroke. 44:2414–2421. 2013.

148. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: a long-term follow-up study. Stroke. 32:485–491. 2001.

149. Juvela S, Siironen J, Kuhmonen J. Hyperglycemia, excess weight, and history of hypertension as risk factors for poor outcome and cerebral infarction after aneurysmal subarachnoid hemorrhage. J Neurosurg. 102:998–1003. 2005.

150. Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 34:196–202. 2006.

151. Kalra VB, Wu X, Matouk CC, Malhotra A. Use of follow-up imaging in isolated perimesencephalic subarachnoid hemorrhage: a meta-analysis. Stroke. 46:401–406. 2015.

152. Kamphuisen PW, Agnelli G. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Thromb Res. 119:265–274. 2007.

153. Kan P, Jahshan S, Yashar P, Orion D, Webb S, Siddiqui AH, et al. Feasibility, safety, and periprocedural complications associated with endovascular treatment of selected ruptured aneurysms under conscious sedation and local anesthesia. Neurosurgery. 72:216–220. discussion 220. 2013.

154. Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm study. Neurosurgery. 13:479–481. 1983.

155. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP. The International Cooperative study on the timing of aneurysm surgery. Part 2: surgical results. J Neurosurg. 73:37–47. 1990.

156. Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery. 56:895–902. discussion 895–902. 2005.

157. Katayama Y, Haraoka J, Hirabayashi H, Kawamata T, Kawamoto K, Kitahara T, et al. A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage. Stroke. 38:2373–2375. 2007.

158. Kato Y, Sano H, Dong PT, Panji N, Itezawa Y, Hayashi J, et al. The effect of clipping and coiling in acute severe subarachnoid hemorrhage after international subarachnoid aneurysmal trial (ISAT) results. Minim Invasive Neurosurg. 48:224–227. 2005.

159. Khan SA, Agrawal A, Hailey CE, Smith TP, Gokhale S, Alexander MJ, et al. Effect of surgical clipping versus endovascular coiling on recovery from oculomotor nerve palsy in patients with posterior communicating artery aneurysms: a retrospective comparative study and meta-analysis. Asian J Neurosurg. 8:117–124. 2013.

160. Khan SA, McDonagh DL, Adogwa O, Gokhale S, Toche UN, Verla T, et al. Perioperative cardiac complications and 30-day mortality in patients undergoing intracranial aneurysmal surgery with adenosine-induced flow arrest: a retrospective comparative study. Neurosurgery. 74:267–271. discussion 271–272. 2014.

161. Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 7:256–267. 2008.

162. Kim TY, Huh SK, Lee JW, Lee KC. Risk factors of seizures associated with the management of ruptured cerebral aneurysms. Korean J Cerebrovasc Surg. 8:10–14. 2006.

163. Kim YJ, Chun MH. The effect of postoperative anticonvulsant prophylaxis after aneurysmal subarachnoid hemorrhage. J Korean Acad Rehabil Med. 27:840–844. 2003.

164. Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD; STASH Collaborators. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 13:666–675. 2014.

165. Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, et al. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 33:1321–1326. 2002.

166. Klimo P Jr, Kestle JR, MacDonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 100:215–224. 2004.

167. Klopfenstein JD, Kim LJ, Feiz-Erfan I, Hott JS, Goslar P, Zabramski JM, et al. Comparison of rapid and gradual weaning from external ventricular drainage in patients with aneurysmal subarachnoid hemorrhage: a prospective randomized trial. J Neurosurg. 100:225–229. 2004.

168. Koivisto T, Vanninen R, Hurskainen H, Saari T, Hernesniemi J, Vapalahti M. Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study. Stroke. 31:2369–2377. 2000.

169. Korja M, Lehto H, Juvela S. Lifelong rupture risk of intracranial aneurysms depends on risk factors: a prospective Finnish Cohort study. Stroke. 45:1958–1963. 2014.

170. Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 45:148–154. 1976.

171. Kowalski RG, Claassen J, Kreiter KT, Bates JE, Ostapkovich ND, Connolly ES, et al. Initial misdiagnosis and outcome after subarachnoid hemorrhage. JAMA. 291:866–869. 2004.

172. Kramer AH, Fletcher JJ. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 14:489–499. 2011.

173. Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med. 36:2070–2075. 2008.

174. Kramer AH, Roberts DJ, Holodinsky J, Todd S, Hill MD, Zygun DA, et al. Intraventricular tissue plasminogen activator in subarachnoid hemorrhage patients: a prospective, randomized, placebo-controlled pilot trial. Neurocrit Care. 21:275–284. 2014.

175. Kronvall E, Undrén P, Romner B, Säveland H, Cronqvist M, Nilsson OG. Nimodipine in aneurysmal subarachnoid hemorrhage: a randomized study of intravenous or peroral administration. J Neurosurg. 110:58–63. 2009.

176. Kruyt ND, Roos YW, Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ, et al. High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 79:1382–1385. 2008.

177. Kshettry VR, Rosenbaum BP, Seicean A, Kelly ML, Schiltz NK, Weil RJ. Incidence and risk factors associated with in-hospital venous thromboembolism after aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 21:282–286. 2014.

178. Kwakkel G. Impact of intensity of practice after stroke: issues for consideration. Disabil Rehabil. 28:823–830. 2006.

179. Kwakkel G, van Peppen R, Wagenaar RC, Wood Dauphinee S, Richards C, Ashburn A, et al. Effects of augmented exercise therapy time after stroke: a meta-analysis. Stroke. 35:2529–2539. 2004.

180. Kwakkel G, Wagenaar RC, Koelman TW, Lankhorst GJ, Koetsier JC. Effects of intensity of rehabilitation after stroke. A research synthesis. Stroke. 28:1550–1556. 1997.

181. Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology. 65:865–869. 2005.

182. Laidlaw JD, Siu KH. Ultra-early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg. 97:250–258. discussion 247–249. 2002.

183. Lakhani S, Guha A, Nahser HC. Anaesthesia for endovascular management of cerebral aneurysms. Eur J Anaesthesiol. 23:902–913. 2006.

184. Langhorne P, Wagenaar R, Partridge C. Physiotherapy after stroke: more is better? Physiother Res Int. 1:75–88. 1996.

185. Lanzino G, Kassell NF, Germanson T, Truskowski L, Alves W. Plasma glucose levels and outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 79:885–891. 1993.

186. Latorre JG, Chou SH, Nogueira RG, Singhal AB, Carter BS, Ogilvy CS, et al. Effective glycemic control with aggressive hyperglycemia management is associated with improved outcome in aneurysmal subarachnoid hemorrhage. Stroke. 40:1644–1652. 2009.

187. Le Roux PD, Elliott JP, Downey L, Newell DW, Grady MS, Mayberg MR, et al. Improved outcome after rupture of anterior circulation aneurysms: a retrospective 10-year review of 224 good-grade patients. J Neurosurg. 83:394–402. 1995.

188. Le Roux PD, Elliott JP, Newell DW, Grady MS, Winn HR. Predicting outcome in poor grade patients with subarachnoid hemorrhage: a retrospective review of 159 aggressively managed cases. J Neurosurg. 85:39–49. 1996.

189. Lee SH, Lim JS, Kim N, Yoon BW. Effects of admission glucose level on mortality after subarachnoid hemorrhage: a comparison between short-term and long-term mortality. J Neurol Sci. 275:18–21. 2008.

190. Levati A, Tommasino C, Moretti MP, Paino R, D’Aliberti G, Santoro F, et al. Giant intracranial aneurysms treated with deep hypothermia and circulatory arrest. J Neurosurg Anesthesiol. 19:25–30. 2007.

191. Li H, Pan R, Wang H, Rong X, Yin Z, Milgrom DP, et al. Clipping versus coiling for ruptured intracranial aneurysms: a systematic review and meta-analysis. Stroke. 44:29–37. 2013.

192. Lindsay KW, Teasdale G, Knill-Jones RP, Murray L. Observer variability in grading patients with subarachnoid hemorrhage. J Neurosurg. 56:628–633. 1982.

193. Locksley HB. Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. J Neurosurg. 25:321–368. 1966.

194. Longstreth WT Jr, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid hemorrhage. Stroke. 23:1242–1249. 1992.

195. Luo YC, Shen CS, Mao JL, Liang CY, Zhang Q, He ZJ. Ultra-early versus delayed coil treatment for ruptured poor-grade aneurysm. Neuroradiology. 57:205–210. 2015.

196. Luostarinen T, Takala RS, Niemi TT, Katila AJ, Niemelä M, Hernesniemi J, et al. Adenosine-induced cardiac arrest during intraoperative cerebral aneurysm rupture. World Neurosurg. 73:79–83. discussion e9. 2010.

197. Lusseveld E, Brilstra EH, Nijssen PC, van Rooij WJ, Sluzewski M, Tulleken CA, et al. Endovascular coiling versus neurosurgical clipping in patients with a ruptured basilar tip aneurysm. J Neurol Neurosurg Psychiatry. 73:591–593. 2002.

198. Ma Z, Wang Q, Liu M. Early versus delayed mobilisation for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. (5):CD008346. 2013.

199. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 10:618–625. 2011.

200. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 43:1463–1469. 2012.

201. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 39:3015–3021. 2008.

202. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol. 3:256–263. 2007.

203. Mack WJ, Ducruet AF, Angevine PD, Komotar RJ, Shrebnick DB, Edwards NM, et al. Deep hypothermic circulatory arrest for complex cerebral aneurysms: lessons learned. Neurosurgery. 60:815–827. discussion 815–827. 2007.

204. Mack WJ, Ducruet AF, Hickman ZL, Kalyvas JT, Cleveland JR, Mocco J, et al. Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis. Neurol Res. 30:889–892. 2008.

205. Manninen PH, Chan AS, Papworth D. Conscious sedation for interventional neuroradiology: a comparison of midazolam and propofol infusion. Can J Anaesth. 44:26–30. 1997.

206. Maslehaty H, Petridis AK, Barth H, Mehdorn HM. Diagnostic value of magnetic resonance imaging in perimesencephalic and nonperimesencephalic subarachnoid hemorrhage of unknown origin. J Neurosurg. 114:1003–1007. 2011.

207. Matsuda M, Watanabe K, Saito A, Matsumura K, Ichikawa M. Circumstances, activities, and events precipitating aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 16:25–29. 2007.

208. McCormack RF, Hutson A. Can computed tomography angiography of the brain replace lumbar puncture in the evaluation of acute-onset headache after a negative noncontrast cranial computed tomography scan? Acad Emerg Med. 17:444–451. 2010.

209. McDougall CG, Halbach VV, Dowd CF, Higashida RT, Larsen DW, Hieshima GB. Endovascular treatment of basilar tip aneurysms using electrolytically detachable coils. J Neurosurg. 84:393–399. 1996.

210. McDougall CG, Spetzler RF, Zabramski JM, Partovi S, Hills NK, Nakaji P, et al. The barrow ruptured aneurysm trial. J Neurosurg. 116:135–144. 2012.

211. McGirt MJ, Woodworth GF, Ali M, Than KD, Tamargo RJ, Clatterbuck RE. Persistent perioperative hyperglycemia as an independent predictor of poor outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg. 107:1080–1085. 2007.

212. McIver JI, Friedman JA, Wijdicks EF, Piepgras DG, Pichelmann MA, Toussaint LG 3rd, et al. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage. J Neurosurg. 97:1042–1044. 2002.

213. McKinney AM, Palmer CS, Truwit CL, Karagulle A, Teksam M. Detection of aneurysms by 64-section multidetector CT angiography in patients acutely suspected of having an intracranial aneurysm and comparison with digital subtraction and 3D rotational angiography. AJNR Am J Neuroradiol. 29:594–602. 2008.

214. McNeill L, English SW, Borg N, Matta BF, Menon DK. Effects of institutional caseload of subarachnoid hemorrhage on mortality: a secondary analysis of administrative data. Stroke. 44:647–652. 2013.

215. Menke J, Larsen J, Kallenberg K. Diagnosing cerebral aneurysms by computed tomographic angiography: meta-analysis. Ann Neurol. 69:646–654. 2011.

216. Milhorat TH. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery. 20:15–20. 1987.

217. Mir DI, Gupta A, Dunning A, Puchi L, Robinson CL, Epstein HA, et al. CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. AJNR Am J Neuroradiol. 35:866–871. 2014.

218. Mitchell P, Kerr R, Mendelow AD, Molyneux A. Could late rebleeding overturn the superiority of cranial aneurysm coil embolization over clip ligation seen in the international subarachnoid aneurysm trial? J Neurosurg. 108:437–442. 2008.

219. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 360:1267–1274. 2002.

220. Molyneux AJ, Birks J, Clarke A, Sneade M, Kerr RS. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the international subarachnoid aneurysm trial (ISAT). Lancet. 385:691–697. 2015.

221. Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the international subarachnoid aneurysm trial (ISAT): long-term follow-up. Lancet Neurol. 8:427–433. 2009.

222. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 366:809–817. 2005.

223. Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 91:947–952. 1999.

224. Mount DB. The brain in hyponatremia: both culprit and victim. Semin Nephrol. 29:196–215. 2009.

225. Murphy-Human T, Welch E, Zipfel G, Diringer MN, Dhar R. Comparison of short-duration levetiracetam with extended course phenytoin for seizure prophylaxis after subarachnoid hemorrhage. World Neurosurg. 75:269–274. 2011.

226. Naccarato M, Chiodo Grandi F, Dennis M, Sandercock PA. Physical methods for preventing deep vein thrombosis in stroke. Cochrane Database Syst Rev. (8):CD001922. 2010.

227. Naidech AM, Bendok BR, Bernstein RA, Alberts MJ, Batjer HH, Watts CM, et al. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery. 63:212–217. discussion 217–218. 2008.

228. Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery. 59:775–779. discussion 779–780. 2006.

229. Naidech AM, Janjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 62:410–416. 2005.

230. Naidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med. 35:2383–2389. 2007.

231. Naidech AM, Kreiter KT, Janjua N, Ostapkovich N, Parra A, Commichau C, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage. Stroke. 36:583–587. 2005.

232. Naidech AM, Levasseur K, Liebling S, Garg RK, Shapiro M, Ault ML, et al. Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care. 12:181–187. 2010.

233. Naidech AM, Liebling SM, Duran IM, Ault ML. Packed red blood cell age does not impact adverse events or outcomes after subarachnoid haemorrhage. Transfus Med. 21:130–133. 2011.

234. Naidech AM, Shaibani A, Garg RK, Duran IM, Liebling SM, Bassin SL, et al. Prospective, randomized trial of higher goal hemoglobin after subarachnoid hemorrhage. Neurocrit Care. 13:313–320. 2010.

235. Neil-Dwyer G, Walter P, Cruickshank JM, Doshi B, O’Gorman P. Effect of propranolol and phentolamine on myocardial necrosis after subarachnoid haemorrhage. Br Med J. 2:990–992. 1978.

236. Nguyen HP, Zaroff JG, Bayman EO, Gelb AW, Todd MM, Hindman BJ, et al. Perioperative hypothermia (33 degrees C) does not increase the occurrence of cardiovascular events in patients undergoing cerebral aneurysm surgery: findings from the Intraoperative Hypothermia for Aneurysm Surgery Trial. Anesthesiology. 113:327–342. 2010.

237. Ogilvy CS. Neurosurgical clipping versus endovascular coiling of patients with ruptured intracranial aneurysms. Stroke. 34:2540–2542. 2003.

238. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 32:1176–1180. 2001.

239. Olafsson E, Gudmundsson G, Hauser WA. Risk of epilepsy in long-term survivors of surgery for aneurysmal subarachnoid hemorrhage: a population-based study in Iceland. Epilepsia. 41:1201–1205. 2000.

240. Oliveira-Filho J, Ezzeddine MA, Segal AZ, Buonanno FS, Chang Y, Ogilvy CS, et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology. 56:1299–1304. 2001.

241. Olkowski BF, Devine MA, Slotnick LE, Veznedaroglu E, Liebman KM, Arcaro ML, et al. Safety and feasibility of an early mobilization program for patients with aneurysmal subarachnoid hemorrhage. Phys Ther. 93:208–215. 2013.

242. Oshiro EM, Walter KA, Piantadosi S, Witham TF, Tamargo RJ. A new subarachnoid hemorrhage grading system based on the glasgow coma scale: a comparison with the Hunt and Hess and World Federation of Neurological Surgeons scales in a clinical series. Neurosurgery. 41:140–147. discussion 147–148. 1997.

243. Ottenbacher KJ, Jannell S. The results of clinical trials in stroke rehabilitation research. Arch Neurol. 50:37–44. 1993.

244. Pan JW, Zhan RY, Wen L, Tong Y, Wan S, Zhou YY. Ultra-early surgery for poor-grade intracranial aneurysmal subarachnoid hemorrhage: a preliminary study. Yonsei Med J. 50:521–524. 2009.

245. Paré L, Delfino R, Leblanc R. The relationship of ventricular drainage to aneurysmal rebleeding. J Neurosurg. 76:422–427. 1992.

246. Park J, Woo H, Kang DH, Kim YS, Kim MY, Shin IH, et al. Formal protocol for emergency treatment of ruptured intracranial aneurysms to reduce in-hospital rebleeding and improve clinical outcomes. J Neurosurg. 122:383–391. 2015.

247. Pasternak JJ, McGregor DG, Schroeder DR, Lanier WL, Shi Q, Hindman BJ, et al. Hyperglycemia in patients undergoing cerebral aneurysm surgery: its association with long-term gross neurologic and neuropsychological function. Mayo Clin Proc. 83:406–417. 2008.

248. Patel K, Guilfoyle MR, Bulters DO, Kirollos RW, Antoun NM, Higgins JN, et al. Recovery of oculomotor nerve palsy secondary to posterior communicating artery aneurysms. Br J Neurosurg. 28:483–487. 2014.

249. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Hohl CM, Sutherland J, et al. Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA. 310:1248–1255. 2013.

250. Perry JJ, Stiell IG, Sivilotti ML, Bullard MJ, Lee JS, Eisenhauer M, et al. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ. 341:c5204. 2010.

251. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 298:636–642. 1989.

252. Pierot L, Cognard C, Anxionnat R, Ricolfi F; CLARITY Investigators. Remodeling technique for endovascular treatment of ruptured intracranial aneurysms had a higher rate of adequate postoperative occlusion than did conventional coil embolization with comparable safety. Radiology. 258:546–553. 2011.

253. Pierot L, Cognard C, Spelle L, Moret J. Safety and efficacy of balloon remodeling technique during endovascular treatment of intracranial aneurysms: critical review of the literature. AJNR Am J Neuroradiol. 33:12–15. 2012.

254. Polmear A. Sentinel headaches in aneurysmal subarachnoid haemorrhage: what is the true incidence? A systematic review. Cephalalgia. 23:935–941. 2003.

255. Powers CJ, Wright DR, McDonagh DL, Borel CO, Zomorodi AR, Britz GW. Transient adenosine-induced asystole during the surgical treatment of anterior circulation cerebral aneurysms: technical note. Neurosurgery. 67(2 Suppl Operative):461–470. 2010.

256. Proust F, Gérardin E, Derrey S, Lesvèque S, Ramos S, Langlois O, et al. Interdisciplinary treatment of ruptured cerebral aneurysms in elderly patients. J Neurosurg. 112:1200–1207. 2010.

257. Qureshi AI, Suri MF, Khan J, Kim SH, Fessler RD, Ringer AJ, et al. Endovascular treatment of intracranial aneurysms by using guglielmi detachable coils in awake patients: safety and feasibility. J Neurosurg. 94:880–885. 2001.

258. Raaymakers TW. Aneurysms in relatives of patients with subarachnoid hemorrhage: frequency and risk factors. MARS Study Group Magnetic Resonance Angiography in Relatives of patients with subarachnoid hemorrhage. Neurology. 53:982–988. 1999.

259. Rabinstein AA, Lanzino G, Wijdicks EF. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 9:504–519. 2010.

260. Raftopoulos C, Mathurin P, Boscherini D, Billa RF, Van Boven M, Hantson P. Prospective analysis of aneurysm treatment in a series of 103 consecutive patients when endovascular embolization is considered the first option. J Neurosurg. 93:175–182. 2000.

261. Rah UW, Kim YH, Ohn SH, Chun MH, Kim MW, Yoo WK, et al. Clinical practice guideline for stroke rehabilitation in Korea 2012. Brain Neurorehabil. 7(Suppl 1):S1–S75. 2014.

262. Rahman M, Smietana J, Hauck E, Hoh B, Hopkins N, Siddiqui A, et al. Size ratio correlates with intracranial aneurysm rupture status: a prospective study. Stroke. 41:916–920. 2010.

263. Rajshekhar V, Harbaugh RE. Results of routine ventriculostomy with external ventricular drainage for acute hydrocephalus following subarachnoid haemorrhage. Acta Neurochir (Wien). 115:8–14. 1992.

264. Ransom ER, Mocco J, Komotar RJ, Sahni D, Chang J, Hahn DK, et al. External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis. Neurocrit Care. 6:174–180. 2007.

265. Raper DM, Starke RM, Komotar RJ, Allan R, Connolly ES Jr. Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg. 79:682–690. 2013.

266. Ray WZ, Moran CJ, Derdeyn CP, Diringer MN, Dacey RG Jr, Zipfel GJ. Near-complete resolution of angiographic cerebral vasospasm after extreme elevation of mean arterial pressure: case report. Surg Neurol. 72:347–353. discussion 353–354. 2009.

267. Ray WZ, Strom RG, Blackburn SL, Ashley WW, Sicard GA, Rich KM. Incidence of deep venous thrombosis after subarachnoid hemorrhage. J Neurosurg. 110:1010–1014. 2009.

268. Raya AK, Diringer MN. Treatment of subarachnoid hemorrhage. Crit Care Clin. 30:719–733. 2014.

269. Reddy D, Fallah A, Petropoulos JA, Farrokhyar F, Macdonald RL, Jichici D. Prophylactic magnesium sulfate for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care. 21:356–364. 2014.

270. Regli L, Dehdashti AR, Uske A, de Tribolet N. Endovascular coiling compared with surgical clipping for the treatment of unruptured middle cerebral artery aneurysms: an update. Acta Neurochir Suppl. 82:41–46. 2002.

271. Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM. Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology. 55:258–265. 2000.

272. Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke. 29:251–256. 1998.

273. Rivero Rodríguez D, Scherle Matamoros C, Fernández Cúe L, Miranda Hernández JL, Pernas Sánchez Y, Pérez Nellar J. Factors associated with poor outcome for aneurysmal subarachnoid haemorrhage in a series of 334 patients. Neurologia. 32:15–21. 2017.

274. United States Agency for health care policy and research. Acute Pain Management: Operative or Medical Procedures and Trauma: Clinical Practice Guideline. ed 1. Rockville: United States Agency for health care policy and research;1992. p. 1–145.

275. Roessler K, Krawagna M, Dörfler A, Buchfelder M, Ganslandt O. Essentials in intraoperative indocyanine green videoangiography assessment for intracranial aneurysm surgery: conclusions from 295 consecutively clipped aneurysms and review of the literature. Neurosurg Focus. 36:E7. 2014.

276. Ronkainen A, Hernesniemi J, Ryynänen M. Familial subarachnoid hemorrhage in east Finland, 1977–1990. Neurosurgery. 33:787–796. discussion 796–797. 1993.

277. Ronkainen A, Miettinen H, Karkola K, Papinaho S, Vanninen R, Puranen M, et al. Risk of harboring an unruptured intracranial aneurysm. Stroke. 29:359–362. 1998.

278. Roos YB, Rinkel GJ, Vermeulen M, Algra A, van Gijn J. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. (2):CD001245. 2003.

279. Rosenberg NF, Koht A, Naidech AM. Anemia and transfusion after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 25:66–74. 2013.

280. Rosengart AJ, Huo JD, Tolentino J, Novakovic RL, Frank JI, Goldenberg FD, et al. Outcome in patients with subarachnoid hemorrhage treated with antiepileptic drugs. J Neurosurg. 107:253–260. 2007.

281. Rowe AS, Goodwin H, Brophy GM, Bushwitz J, Castle A, Deen D, et al. Seizure prophylaxis in neurocritical care: a review of evidence-based support. Pharmacotherapy. 34:396–409. 2014.

282. Royal College of Physicians. National Clinical Guideline for Stroke. ed 4. London: Royal College of Physicians of London;2012. p. 79–123.

283. Ruigrok YM, Buskens E, Rinkel GJ. Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke. 32:1173–1175. 2001.

284. Ryttlefors M, Enblad P, Kerr RS, Molyneux AJ. International subarachnoid aneurysm trial of neurosurgical clipping versus endovascular coiling: subgroup analysis of 278 elderly patients. Stroke. 39:2720–2726. 2008.

285. Sakurai J, Ushikoshi S, Terasaka S, Kazumata K, Asaoka K, Ajiki M, et al. The role of endovascular treatment for multiple intracranial aneurysms with subarachnoid hemorrhage. No Shinkei Geka. 35:143–149. 2007.

286. Sankai T, Iso H, Shimamoto T, Kitamura A, Naito Y, Sato S, et al. Prospective study on alcohol intake and risk of subarachnoid hemorrhage among Japanese men and women. Alcohol Clin Exp Res. 24:386–389. 2000.

287. Santillan A, Knopman J, Zink W, Patsalides A, Gobin YP. Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery. 69:95–101. discussion 102. 2011.

288. Sano H, Satoh A, Murayama Y, Kato Y, Origasa H, Inamasu J, et al. Modified World Federation of Neurosurgical Societies subarachnoid hemorrhage grading system. World Neurosurg. 83:801–807. 2015.

289. Sarker SJ, Heuschmann PU, Burger I, Wolfe CD, Rudd AG, Smeeton NC, et al. Predictors of survival after haemorrhagic stroke in a multi-ethnic population: the South London Stroke Register (SLSR). J Neurol Neurosurg Psychiatry. 79:260–265. 2008.

290. Sayama T, Inamura T, Matsushima T, Inoha S, Inoue T, Fukui M. High incidence of hyponatremia in patients with ruptured anterior communicating artery aneurysms. Neurol Res. 22:151–155. 2000.

291. Schaafsma JD, Sprengers ME, van Rooij WJ, Sluzewski M, Majoie CB, Wermer MJ, et al. Long-term recurrent subarachnoid hemorrhage after adequate coiling versus clipping of ruptured intracranial aneurysms. Stroke. 40:1758–1763. 2009.

292. Schebesch KM, Proescholdt M, Ullrich OW, Camboni D, Moritz S, Wiesenack C, et al. Circulatory arrest and deep hypothermia for the treatment of complex intracranial aneurysms--results from a single European center. Acta Neurochir (Wien). 152:783–792. 2010.

293. Schievink WI, Schaid DJ, Michels VV, Piepgras DG. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg. 83:426–429. 1995.

294. Schmidt JM, Crimmins M, Lantigua H, Fernandez A, Zammit C, Falo C, et al. Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage. Neurocrit Care. 20:390–398. 2014.

295. Schuss P, Güresir E, Berkefeld J, Seifert V, Vatter H. Influence of surgical or endovascular treatment on visual symptoms caused by intracranial aneurysms: single-center series and systematic review. J Neurosurg. 115:694–699. 2011.

296. Seiler RW, Reulen HJ, Huber P, Grolimund P, Ebeling U, Steiger HJ. Outcome of aneurysmal subarachnoid hemorrhage in a hospital population: a prospective study including early operation, intravenous nimodipine, and transcranial doppler ultrasound. Neurosurgery. 23:598–604. 1988.

297. Seo DH, Kang HS, Kim DW, Park SQ, Song Y, Sheen SH, et al. Guidelines for the management of unruptured intracranial aneurysm. Korean J Cerebrovasc Surg. 13:279–290. 2011.

298. Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 53:123–128. 2011.

299. Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg. 119:180–189. 2013.

300. Shen X, Xu T, Ding X, Wang W, Liu Z, Qin H. Multiple intracranial aneurysms: endovascular treatment and complications. Interv Neuroradiol. 20:442–447. 2014.

301. Shimamura N, Matsuda N, Satou J, Nakano T, Ohkuma H. Early ambulation produces favorable outcome and nondemential state in aneurysmal subarachnoid hemorrhage patients older than 70 years of age. World Neurosurg. 81:330–334. 2014.

302. Shimoda M, Hoshikawa K, Shiramizu H, Oda S, Matsumae M. Problems with diagnosis by fluid-attenuated inversion recovery magnetic resonance imaging in patients with acute aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 50:530–537. 2010.

303. Siironen J, Juvela S, Varis J, Porras M, Poussa K, Ilveskero S, et al. No effect of enoxaparin on outcome of aneurysmal subarachnoid hemorrhage: a randomized, double-blind, placebo-controlled clinical trial. J Neurosurg. 99:953–959. 2003.

304. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg. 101:1–7. 2004.

305. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 35:2518–2522. 2004.

306. Solenski NJ, Haley EC Jr, Kassell NF, Kongable G, Germanson T, Truskowski L, et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study. Participants of the multicenter cooperative aneurysm study. Crit Care Med. 23:1007–1017. 1995.

307. Solomon RA, Smith CR, Raps EC, Young WL, Stone JG, Fink ME. Deep hypothermic circulatory arrest for the management of complex anterior and posterior circulation aneurysms. Neurosurgery. 29:732–737. discussion 737–738. 1991.

308. Spetzler RF, Hadley MN, Rigamonti D, Carter LP, Raudzens PA, Shedd SA, et al. Aneurysms of the basilar artery treated with circulatory arrest, hypothermia, and barbiturate cerebral protection. J Neurosurg. 68:868–879. 1988.

309. Spetzler RF, McDougall CG, Albuquerque FC, Zabramski JM, Hills NK, Partovi S, et al. The Barrow Ruptured Aneurysm Trial: 3-year results. J Neurosurg. 119:146–157. 2013.

310. Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, et al. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage. Stroke. 39:2617–2621. 2008.

311. Stein M, Brokmeier L, Herrmann J, Scharbrodt W, Schreiber V, Bender M, et al. Mean hemoglobin concentration after acute subarachnoid hemorrhage and the relation to outcome, mortality, vasospasm, and brain infarction. J Clin Neurosci. 22:530–534. 2015.

312. Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G, et al. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 35:93–112. 2012.

313. Sunderland A, Tinson DJ, Bradley EL, Fletcher D, Langton Hewer R, Wade DT. Enhanced physical therapy improves recovery of arm function after stroke: A randomized controlled trial. J Neurol Neurosurg Psychiatry. 55:530–535. 1992.

314. Sundquist J, Li X, Sundquist K, Hemminki K. Risks of subarachnoid hemorrhage in siblings: a nationwide epidemiological study from Sweden. Neuroepidemiology. 29:178–184. 2007.

315. Tagami T, Kuwamoto K, Watanabe A, Unemoto K, Yokobori S, Matsumoto G, et al. Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care. 21:462–469. 2014.

316. Tagami T, Kuwamoto K, Watanabe A, Unemoto K, Yokobori S, Matsumoto G, et al. Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid hemorrhage: a multicenter prospective cohort study. Crit Care Med. 42:1348–1356. 2014.

317. Takebayashi S, Kamiyama H, Takizawa K, Kobayashi T, Saitoh N. The significance of intraoperative monitoring of muscle motor evoked potentials during unruptured large and giant cerebral aneurysm surgery. Neurol Med Chir (Tokyo). 54:180–188. 2014.

318. Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M. Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Neurosurgery. 28:41–48. 1991.

319. Takeuchi S, Mori K, Arimoto H, Fujii K, Nagatani K, Tomura S, et al. Effects of intravenous infusion of hydrogen-rich fluid combined with intracisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial. BMC Neurol. 14:176. 2014.

320. Taylor CJ, Robertson F, Brealey D, O’shea F, Stephen T, Brew S, et al. Outcome in poor grade subarachnoid hemorrhage patients treated with acute endovascular coiling of aneurysms and aggressive intensive care. Neurocrit Care. 14:341–347. 2011.

321. Terry A, Zipfel G, Milner E, Cross DT 3rd, Moran CJ, Diringer MN, et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus. 21:E14. 2006.

322. Tewari M, Aggarwal A, Mathuriya S, Gupta V. The outcome after aneurysmal sub arachnoid hemorrhage: a study of various factors. Ann Neurosci. 22:78–80. 2015.

323. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS, et al. Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology. 110:603–610. 2009.

324. Todd MM, Hindman BJ, Clarke WR, Torner JC; Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 352:135–145. 2005.

325. Togashi K, Joffe AM, Sekhar L, Kim L, Lam A, Yanez D, et al. Randomized pilot trial of intensive management of blood pressure or volume expansion in subarachnoid hemorrhage (IMPROVES). Neurosurgery. 76:125–134. discussion 134–135; quiz 135. 2015.

326. Tseng MY, Al-Rawi PG, Czosnyka M, Hutchinson PJ, Richards H, Pickard JD, et al. Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage. J Neurosurg. 107:274–282. 2007.

327. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke. 34:1389–1396. 2003.

328. Tseng MY, Hutchinson PJ, Richards HK, Czosnyka M, Pickard JD, Erber WN, et al. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a phase II randomized, double-blind, placebo-controlled trial. Clinical article. J Neurosurg. 111:171–180. 2009.

329. Tsutsumi K, Ueki K, Morita A, Usui M, Kirino T. Risk of aneurysm recurrence in patients with clipped cerebral aneurysms: results of long-term follow-up angiography. Stroke. 32:1191–1194. 2001.

330. Vale FL, Bradley EL, Fisher WS 3rd. The relationship of subarachnoid hemorrhage and the need for postoperative shunting. J Neurosurg. 86:462–466. 1997.

331. van der Bilt IA, Hasan D, Vandertop WP, Wilde AA, Algra A, Visser FC, et al. Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology. 72:635–642. 2009.

332. van der Schaaf I, Wermer MJ, van der Graaf Y, Hoff RG, Rinkel GJ, Velthuis BK. CT after subarachnoid hemorrhage: relation of cerebral perfusion to delayed cerebral ischemia. Neurology. 66:1533–1538. 2006.

333. van Heuven AW, Dorhout Mees SM, Algra A, Rinkel GJ. Validation of a prognostic subarachnoid hemorrhage grading scale derived directly from the glasgow coma scale. Stroke. 39:1347–1348. 2008.

334. van Loon J, Waerzeggers Y, Wilms G, Van Calenbergh F, Goffin J, Plets C. Early endovascular treatment of ruptured cerebral aneurysms in patients in very poor neurological condition. Neurosurgery. 50:457–464. discussion 464–465. 2002.

335. Varelas P, Helms A, Sinson G, Spanaki M, Hacein-Bey L. Clipping or coiling of ruptured cerebral aneurysms and shunt-dependent hydrocephalus. Neurocrit Care. 4:223–228. 2006.

336. Varma MK, Price K, Jayakrishnan V, Manickam B, Kessell G. Anaesthetic considerations for interventional neuroradiology. Br J Anaesth. 99:75–85. 2007.

337. Veerbeek JM, Koolstra M, Ket JC, van Wegen EE, Kwakkel G. Effects of augmented exercise therapy on outcome of gait and gait-related activities in the first 6 months after stroke: a meta-analysis. Stroke. 42:3311–3315. 2011.

338. Vergouwen MD, Algra A, Rinkel GJ. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke. 43:2671–2676. 2012.

339. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke. 41:e47–e52. 2010.

340. Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and obser vational studies: proposal of a multidisciplinary research group. Stroke. 41:2391–2395. 2010.

341. Vermeij FH, Hasan D, Vermeulen M, Tanghe HL, van Gijn J. Predictive factors for deterioration from hydrocephalus after subarachnoid hemorrhage. Neurology. 44:1851–1855. 1994.

342. Wang PS, Longstreth WT Jr, Koepsell TD. Subarachnoid hemorrhage and family history. A population-based case-control study. Arch Neurol. 52:202–204. 1995.

343. Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials. PLoS One. 7:e47778. 2012.

344. Wartenberg KE, Parra A. CT and CT-perfusion findings of reversible leukoencephalopathy during triple-H therapy for symptomatic subarachnoid hemorrhage-related vasospasm. J Neuroimaging. 16:170–175. 2006.

345. Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 34:617–623. quiz 624. 2006.

346. Wermer MJ, Koffijberg H, van der Schaaf IC; ASTRA Study Group. Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology. 70:2053–2062. 2008.

347. Wermer MJ, van der Schaaf IC, Velthuis BK, Algra A, Buskens E, Rinkel GJ, et al. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain. 128(Pt 10):2421–2429. 2005.

348. Westermaier T, Pham M, Stetter C, Willner N, Solymosi L, Ernestus RI, et al. Value of transcranial doppler, perfusion-CT and neurological evaluation to forecast secondary ischemia after aneurysmal SAH. Neurocrit Care. 20:406–412. 2014.

349. Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 362:103–110. 2003.

350. Willinsky RA, Peltz J, da Costa L, Agid R, Farb RI, terBrugge KG. Clinical and angiographic follow-up of ruptured intracranial aneurysms treated with endovascular embolization. AJNR Am J Neuroradiol. 30:1035–1040. 2009.

351. Winn HR, Richardson AE, Jane JA. The long-term prognosis in untreated cerebral aneurysms: I. The incidence of late hemorrhage in cerebral aneurysm: a 10-year evaluation of 364 patients. Ann Neurol. 1:358–370. 1977.

352. Wong GK, Chan DY, Siu DY, Zee BC, Poon WS, Chan MT, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial. Stroke. 46:382–388. 2015.

353. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke. 41:921–926. 2010.

354. Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab. 18:419–424. 1998.

355. Zhao XD, Zhou YT, Zhang X, Zhuang Z, Shi JX. A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neurosci. 16:1394–1397. 2009.

356. Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke. 39:1759–1765. 2008.

357. Post-stroke rehabilitation: assessment, referral and patient management. Post-stroke rehabilitation guideline panel. Agency for Health Care Policy and Research. Am Fam Physician. 52:461–470. 1995.

358. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 68:985–986. 1988.